F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R.160-Protect Medical Innovation Act of 2015 S.149-Medical Device Access and Innovation Protection Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| RUSSELL CONWELL RING | VP Government Affairs Roche Diagnostics Diabetes |
Health Issues HCR
H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015 Yet to be introduced Senate proposal on Medicare competitive bidding proposal related to diabetes supplies HPV NCCI Language Competitive bidding HR 771
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN A CLAESSENS | Sr. Director Federal Health Policy & Reimbursement |
| RUSSELL CONWELL RING | VP Government Affairs Roche Diagnostics Diabetes |
| BRUCE THOMAS TAYLOR | Director Government Strategy & Relations |
Medicare/Medicaid MMM
Medicare competitive bidding program for diabetes testing supplies (for DACC, of which Roche is a member [1/3 share]). Medicare payment for point of care laboratory testing (for POCTA of which Roche is a member [1/5 share]). Policies related to diagnostic laboratory testing, H.R. 771 "Protecting Access to Diabetic Supplies"; S. 1101 "Medical Electronic Data Technology Enhancement for Consumers Health Act"; H.R. 6 "21st Century Cures Act";
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE THOMAS TAYLOR | Director Government Strategy & Relations |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.